These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6418754)

  • 21. Evaluation of the AutoMicrobic system Gram-Negative General Susceptibility-Plus Card.
    Van Horn KG; Vandernoot AM; Burke EW; McKitrick JC
    J Clin Microbiol; 1984 Oct; 20(4):630-5. PubMed ID: 6490849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of cefepime/zidebactam (WCK 5222) against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii endemic to New York City medical centres.
    Khan Z; Iregui A; Landman D; Quale J
    J Antimicrob Chemother; 2019 Oct; 74(10):2938-2942. PubMed ID: 31298277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid antimicrobial susceptibility testing by VITEK®2 directly from blood cultures in patients with Gram-negative rod bacteremia.
    Hogan CA; Watz N; Budvytiene I; Banaei N
    Diagn Microbiol Infect Dis; 2019 Jun; 94(2):116-121. PubMed ID: 30711413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of rapidity and quality for the VITEK susceptibility cards with 45 wells].
    Miyamoto H; Handa T; Inoue C; Murase M
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 1998; 9(2):55-8. PubMed ID: 10036375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in the Asia-Pacific region (minus China, Australia and New Zealand): report from an Antimicrobial Surveillance Programme (2013-2015).
    Pfaller MA; Shortridge D; Sader HS; Castanheira M; Flamm RK
    Int J Antimicrob Agents; 2018 Feb; 51(2):181-189. PubMed ID: 28993143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase].
    López-Yeste M; Xercavins M; Lite J; Cuchí E; Garau J
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):211-4. PubMed ID: 9044634
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Karlowsky JA; Kazmierczak KM; Bouchillon SK; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin.
    Tan TY; Ng SY
    Clin Microbiol Infect; 2007 May; 13(5):541-4. PubMed ID: 17371537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid automated antimicrobial susceptibility testing of Streptococcus pneumoniae by use of the bioMerieux VITEK 2.
    Jorgensen JH; Barry AL; Traczewski MM; Sahm DF; McElmeel ML; Crawford SA
    J Clin Microbiol; 2000 Aug; 38(8):2814-8. PubMed ID: 10921932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter Evaluation of the Etest Gradient Diffusion Method for Ceftolozane-Tazobactam Susceptibility Testing of Enterobacteriaceae and Pseudomonas aeruginosa.
    Bailey AL; Armstrong T; Dwivedi HP; Denys GA; Hindler J; Campeau S; Traczewski M; Humphries R; Burnham CA
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the
    Yin D; Wu S; Yang Y; Shi Q; Dong D; Zhu D; Hu F;
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30617091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae.
    Steward CD; Stocker SA; Swenson JM; O'Hara CM; Edwards JR; Gaynes RP; McGowan JE; Tenover FC
    J Clin Microbiol; 1999 Mar; 37(3):544-7. PubMed ID: 9986809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproducibility between two readout methods of a commercial broth microdilution assay for Pseudomonas aeruginosa isolates from patients with Cystic Fibrosis.
    Franssens BT; Fluit AC; Rentenaar RJ
    Infect Dis (Lond); 2019 Jan; 51(1):50-55. PubMed ID: 30654670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of disk diffusion, VITEK 2, and broth microdilution antimicrobial susceptibility test results for unusual species of Enterobacteriaceae.
    Stone ND; O'Hara CM; Williams PP; McGowan JE; Tenover FC
    J Clin Microbiol; 2007 Feb; 45(2):340-6. PubMed ID: 17135429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Australia and New Zealand: Report from an Antimicrobial Surveillance Program (2013-2015).
    Pfaller MA; Shortridge D; Sader HS; Flamm RK; Castanheira M
    J Glob Antimicrob Resist; 2017 Sep; 10():186-194. PubMed ID: 28735046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.
    Castanheira M; Duncan LR; Mendes RE; Sader HS; Shortridge D
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosing strategy based on prevailing aminoglycoside minimum inhibitory concentration in India: Evidence and issues.
    Veeraraghavan B; Pragasam AK; Manesh A; Rupali P; Iyadurai R; Rodrigues C; Joshi S; Roy I; Chaudhuri BN; Chitnis DS; Tapan D
    Indian J Med Microbiol; 2017; 35(4):585-587. PubMed ID: 29405154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates.
    Steward CD; Mohammed JM; Swenson JM; Stocker SA; Williams PP; Gaynes RP; McGowan JE; Tenover FC
    J Clin Microbiol; 2003 Jan; 41(1):351-8. PubMed ID: 12517872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.